Christine Johnston is an Infectious Disease physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1959 NE Pacific St
C212, Box 356340
Seattle, WA 981956340
Telephone
206-543-0065Registry record last updated 8 Jul 2007.
Clinical trials
- VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination
Sponsor: University of Washington
- Treatment for COVID-19 in High-Risk Adult Outpatients
Sponsor: University of Washington
- HSV529 Vaccine in HSV-2 Seropositive Adults
Sponsor: Fred Hutchinson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
- GlaxoSmithKline, LLC.Program year20242 payments
- GlaxoSmithKline, LLC.Program year20232 payments$15,794openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
33.8%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor12.3%Tivicay100%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor12.3%Descovy100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
32.4%ACE inhibitor18.5%Lisinopril100%Part D<11 patientsStatin10.6%Atorvastatin Calcium54%Rosuvastatin Calcium46%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
9.8%Proton pump inhibitor3.5%Omeprazole100%Part D<11 patientsBiguanide (metformin)3.3%Metformin Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2008–2023 per NIH RePORTER. The latest:
- Modulation of Alzheimers disease by Herpes simplex virus infection
University of Washington
FY2023$430,231R01AG062514 - Modulation of Alzheimers disease by Herpes simplex virus infection
University of Washington
FY2022$513,438R01AG062514 - Modulation of Alzheimers disease by Herpes simplex virus infection
University of Washington
FY2021$554,804R01AG062514
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”